| Pretraživanje | Osvježi |
|
Atriva Therapeutics
@AtrivaTx
|
13. sij |
|
Learn more about @AtrivaTx’s host-targeting therapy candidate #ATR002 against #flu, hanta and further severe respiratory viral infections at the company presentation of our CEO, Dr. Lichtenberger, today at #BiotechShowcase. Join us at 11:30, Franciscan D. bit.ly/39PxxWE pic.twitter.com/4C0P2MzBMb
|
||
|
||
|
AllTime EDM
@AllTimeEDM
|
29. lip |
|
THIS ONES FOR ALL YOU DUBSTEP LOVERS 😤
#ATR002 soundcloud.com/alltimeedm/all…
|
||
|
|
||
|
AllTime EDM
@AllTimeEDM
|
27. lip |
|
||
|
Atriva Therapeutics
@AtrivaTx
|
20. lis |
|
Atriva Theraputics is now also on Twitter! We can’t wait to
tell you more about our lead product #ATR002, a clinical-
stage, first-in-class host-targeting agent that inhibits viral
replication in #influenza and other respiratory infections.
Stay tuned! pic.twitter.com/pNCZdmmkDn
|
||
|
||
|
Atriva Therapeutics
@AtrivaTx
|
14. sij |
|
We look forward to telling you more about #ATR002, our host-targeting approach to treat #flu, at the RESI conference, where 500+ early stage investors gather every year. Dr. Rainer Lichtenberger will present Atriva during the track 4, 8:00 am. @LSciNation bit.ly/2N0MUlh pic.twitter.com/is4vr7crmV
|
||
|
||
|
Atriva Therapeutics
@AtrivaTx
|
4. stu |
|
On Nov 11 #BIOEurope, EU's largest life science partnering conference, starts in #Hamburg. Our CEO Dr. Lichtenberger is happy to discuss our lead product #ATR002 against #influenza, #hanta and other severe respiratory infections. Use #partneringONE @EBDgroup to set up a meeting! pic.twitter.com/lDsTrTORhb
|
||
|
||
|
Atriva Therapeutics
@AtrivaTx
|
1. stu |
|
Let’s go #viral by spreading awareness - today is #WorldInfluenzaDay! Atriva commits to #fightflu with our first-in-class host-targeting MEK inhibitor #ATR002. We address the need for a novel, broadly active, resistance-avoiding therapy and for a prolonged treatment window. pic.twitter.com/DxGvbFPfNV
|
||
|
||
|
Atriva Therapeutics
@AtrivaTx
|
30. sij |
|
|
||
|
Atriva Therapeutics
@AtrivaTx
|
29. sij |
|
The world is under virus attack, but German scientists are already on the move. @Tagesspiegel spoke with Prof. Dr. Ludwig, developer of @AtrivaTx’ host-targeting #antiviral candidate, #ATR002, about pandemic threats like #flu, SARS, MERS and #coronavirus. bit.ly/2O7CMrK pic.twitter.com/fT8OSsdVdv
|
||
|
||